GLMD Stock Analysis: Buy, Sell, or Hold?
GLMD - Galmed Pharmaceuticals Ltd.
$0.57
0.00 (-0.42%)
▼
5d:
-5.74%
30d:
-1.81%
90d:
-3.13%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Jun 25, 2026
TODAY
Get Alerted When GLMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: GLMD shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: GLMD shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: GLMD is currently trading at $0.57, which is considered slightly low relative to its 30-day fair value range of $0.55 to $0.69.
Technical Outlook: Technically, GLMD is in a downtrend. Immediate support is located at $0.41, while resistance sits at $0.79.
Market Sentiment: GLMD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $12.00 (+1997.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, GLMD is in a downtrend. Immediate support is located at $0.41, while resistance sits at $0.79.
Market Sentiment: GLMD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $12.00 (+1997.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.55 -
$0.69
Company Quality Score
42/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: Trading 1997.9% below Wall St target ($12.00)
- CAUTION: 5-day price weakness (-5.7%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.55 -
$0.69
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.42
Resistance Level
$0.79
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.64
Wall Street Target
$12.00
(+1997.9%)
Share & Embed Analysis
Last updated: June 24, 2026 11:26 AM ET
Data refreshes hourly during market hours. Next update: 12:26 PM
Data refreshes hourly during market hours. Next update: 12:26 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GLMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 67 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$105 | 64 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 61 BUY |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 65 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 65 BUY |
